SHSE:603168'
s Net Margin % Range Over the Past 10 Years
Min: -59.55 Med: 2.73 Max: 28.17
Current: -59.55
SHSE:603168's Net Margin % is ranked worse than 88.35% of 953
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs SHSE:603168: -59.55
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Zhejiang Shapuaisi Pharmaceutical Co Net Margin % Related Terms
Zhejiang Shapuaisi Pharmaceutical Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Shapuaisi Pharmaceutical Co Net Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shapuaisi Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Shapuaisi Pharmaceutical Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shapuaisi Pharmaceutical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Shapuaisi Pharmaceutical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) has a Net Margin % of -26.50% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors. According to the industry distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #842 out of 953 companies in the Drug Manufacturers industry, placing it in the top 88.4%.
Is Zhejiang Shapuaisi Pharmaceutical Co's Net Margin % too high?
Zhejiang Shapuaisi Pharmaceutical Co's current Net Margin % is -26.50%. Based on the distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #842 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Zhejiang Shapuaisi Pharmaceutical Co has a GF Score™ of 37/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shapuaisi Pharmaceutical Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #842 out of 953 companies for Net Margin %. This places Zhejiang Shapuaisi Pharmaceutical Co in the lower half of its industry. The industry median Net Margin % is 5.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Shapuaisi Pharmaceutical Co's current Net Margin % is -26.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shapuaisi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥8.52, compared to a current price of ¥4.73 — trading 44.5% below its estimated fair value. The current Net Margin % is -26.50%. Zhejiang Shapuaisi Pharmaceutical Co's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168), the current Net Margin % is -26.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥4.73 is trading 44.5% below its estimated GF Value™ of ¥8.52.
GuruFocus considers Zhejiang Shapuaisi Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:603168:
Net Margin %: -26.50%
GF Value™: ¥8.52 vs. price of ¥4.73 (44.5% below fair value)
No single metric tells the full story. See the SHSE:603168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Shapuaisi Pharmaceutical Co Business Description
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
37GF Score
Get the complete analysis for SHSE:603168
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603168 has been successfully added to your 
